Cargando…

Diagnostic and prognostic value of neutrophil gelatinase-associated lipocalin, matrix metalloproteinase-9, and tissue inhibitor of matrix metalloproteinases-1 for sepsis in the Emergency Department: an observational study

INTRODUCTION: The aim of this study was to evaluate the early diagnostic, risk stratification and prognostic value of neutrophil gelatinase-associated lipocalin (NGAL), matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinases-1 (TIMP-1), compared with procalcitonin (PCT)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Miaomiao, Zhang, Qian, Zhao, Xin, Dong, Guijuan, Li, Chunsheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4258267/ https://www.ncbi.nlm.nih.gov/pubmed/25407832 http://dx.doi.org/10.1186/s13054-014-0634-6

Ejemplares similares

Combination of neutrophil gelatinase-associated lipocalin and matrix metalloproteinase-9 are biomarkers for the detection of colon tubular adenocarcinoma
por: Yuan, Jun-Hua, et al.
Publicado: (2021)

Up-regulation of matrix metalloproteinases-9 in the kidneys of diabetic rats and the association with neutrophil gelatinase-associated lipocalin
por: Yang, Huayu, et al.
Publicado: (2021)

An uncommon case of arterial aneurysms association with high plasma levels of Matrix Metalloproteinase-9 and Neutrophil Gelatinase-Associated Lipocalin
por: De Caridi, Giovanni, et al.
Publicado: (2015)

Neutrophil Gelatinase-Associated Lipocalin (NGAL), Pro-Matrix Metalloproteinase-9 (pro-MMP-9) and Their Complex Pro-MMP-9/NGAL in Leukaemias
por: Bouchet, Sandrine, et al.
Publicado: (2014)

Genetic variations and plasma levels of gelatinase A (matrix metalloproteinase-2) and gelatinase B (matrix metalloproteinase-9) in proliferative diabetic retinopathy
por: Beránek, Michal, et al.
Publicado: (2008)

Matrix Metalloproteinase-9/Neutrophil Gelatinase-Associated Lipocalin Complex Activity in Human Glioma Samples Predicts Tumor Presence and Clinical Prognosis
por: Liu, Ming-Fa, et al.
Publicado: (2015)

Circulating levels of matrix metalloproteinase-9 (MMP-9), neutrophil gelatinase-associated lipocalin (NGAL) and their complex MMP-9/NGAL in breast cancer disease
por: Provatopoulou, Xeni, et al.
Publicado: (2009)

Neutrophil gelatinase-associated lipocalin (NGAL) and matrix metalloproteinases as novel stress markers in children and young adults on chronic dialysis
por: Musiał, Kinga, et al.
Publicado: (2010)

Thymocyte development in the absence of matrix metalloproteinase-9/gelatinase B
por: Gounko, Natalia V., et al.
Publicado: (2016)

Evaluation of neutrophil gelatinase-associated lipocalin (NGAL), matrix metalloproteinase-9 (MMP-9) and their complex MMP-9/NGAL in sera and urine of patients with kidney tumors
por: DI CARLO, ANGELINA
Publicado: (2013)

Recent Findings on the Role of Gelatinases (Matrix Metalloproteinase-2 and -9) in Osteoarthritis
por: Galasso, Olimpio, et al.
Publicado: (2012)

Gelatinase B/Matrix Metalloproteinase-9 as Innate Immune Effector Molecule in Achalasia
por: Furuzawa-Carballeda, Janette, et al.
Publicado: (2018)

Matrix Metalloproteinase-9 and Tissue Inhibitor of Matrix Metalloproteinase-1 in Sepsis after Major Abdominal Surgery
por: Bojic, Suzana, et al.
Publicado: (2018)

The prognostic values of matrix metalloproteinases in ovarian cancer
por: Zeng, Linchai, et al.
Publicado: (2019)

Matrix metalloproteinase-9, -10, and tissue inhibitor of matrix metalloproteinases-1 blood levels as biomarkers of severity and mortality in sepsis
por: Lorente, Leonardo, et al.
Publicado: (2009)

Plasma Matrix Metalloproteinase-9 and Tissue Inhibitor of Matrix Metalloproteinase-1 as Prognostic Biomarkers in Critically Ill Patients
por: Duda, Izabela, et al.
Publicado: (2020)

Matrix metalloproteinases 2 and 9 (gelatinases A and B) expression in malignant mesothelioma and benign pleura
por: Edwards, J G, et al.
Publicado: (2003)

Genomic variations within matrix metalloproteinase-9 and severe sepsis
por: Chen, Q, et al.
Publicado: (2009)

The diagnostic value of matrix metalloproteinase 9 (MMP-9) and tissue inhibitor of matrix metalloproteinases 1 (TIMP-1) determination in the sera of colorectal adenoma and cancer patients
por: Mroczko, Barbara, et al.
Publicado: (2010)

Clinical application value of serum neutrophil gelatinase-associated lipocalin in neonatal sepsis
por: Cai, Qun, et al.
Publicado: (2022)

Matrix metalloproteinase-7 and matrix metalloproteinase-9 are associated with unfavourable prognosis in superficial oesophageal cancer
por: Tanioka, Y, et al.
Publicado: (2003)

Interleukin-33, matrix metalloproteinase-9, and tissue ınhibitor of matrix metalloproteinase-1 in myocardial infarction
por: Guzel, Savas, et al.
Publicado: (2013)

Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients
por: Trentini, Alessandro, et al.
Publicado: (2016)

Matrix Metalloproteinase-1 and Matrix Metalloproteinase-9 in the Aqueous Humor of Diabetic Macular Edema Patients
por: Kwon, Jin-woo, et al.
Publicado: (2016)

Matrix metalloproteinases and their inhibitors as biomarkers of severity in sepsis
por: Lorente, Leonardo, et al.
Publicado: (2010)

Prognostic role of matrix metalloproteinase 9 in early breast cancer
por: Kalavska, Katarina, et al.
Publicado: (2021)

Prognostic value of matrix metalloproteinases in oral squamous cell carcinoma
por: Mishev, Georgi, et al.
Publicado: (2014)

Expression of Matrix Metalloproteinases during Rat Skin Wound Healing: Evidence that Membrane Type-1 Matrix Metalloproteinase Is a Stromal Activator of Pro-Gelatinase A
por: Okada, Akiko, et al.
Publicado: (1997)

Erratum: Interleukin-33, matrix metalloproteinase-9, and tissue inhibitor of matrix metalloproteinase-1 in myocardial infarction
por: Guzel, Savas, et al.
Publicado: (2013)

Elevated Expression of Matrix Metalloproteinase-9 not Matrix Metalloproteinase-2 Contributes to Progression of Extracranial Arteriovenous Malformation
por: Wei, Ting, et al.
Publicado: (2016)

Proteoform Analysis of Matrix Metalloproteinase-9/Gelatinase B and Discovery of Its Citrullination in Rheumatoid Arthritis Synovial Fluids
por: Grillet, Bernard, et al.
Publicado: (2021)

Functional relationship between matrix metalloproteinase-11 and matrix metalloproteinase-14
por: Buache, Emilie, et al.
Publicado: (2014)

Expression of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases in the hair cycle
por: HOU, CHUN, et al.
Publicado: (2016)

Green tea catechin inhibits the activity and neutrophil release of Matrix Metalloproteinase-9
por: Kim-Park, Wan K., et al.
Publicado: (2015)

A nutrient mixture reduces the expression of matrix metalloproteinases in an animal model of spinal cord injury by modulating matrix metalloproteinase-2 and matrix metalloproteinase-9 promoter activities
por: ZHANG, HONGQI, et al.
Publicado: (2014)

The association between the preoperative serum levels of lipocalin-2 and matrix metalloproteinase-9 (MMP-9) and prognosis of breast cancer
por: Sung, Hyuna, et al.
Publicado: (2012)

The Effect of Thiamine, Ascorbic Acid, and the Combination of Them on the Levels of Matrix Metalloproteinase-9 (MMP-9) and Tissue Inhibitor of Matrix Metalloproteinase-1 (TIMP-1) in Sepsis Patients
por: Lubis, Bastian, et al.
Publicado: (2022)

Important role of matrix metalloproteinase 9 in epileptogenesis
por: Wilczynski, Grzegorz M., et al.
Publicado: (2008)

Expression of Matrix Metalloproteinase-9 in Gastric Cancer
por: R, Prathipaa, et al.
Publicado: (2021)

Variants of the Matrix Metalloproteinase-2 but not the Matrix Metalloproteinase-9 genes significantly influence functional outcome after stroke
por: Manso, Helena, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_9tcb0rpiml2cnu25jh7titbr5b